OBJECTIVES: To determine whether serum calcium is associated with cognitive function in elderly individuals in the general population. DESIGN: Prospective follow-up study of two independent, population-based cohorts. SETTING: The Rotterdam Study (median follow-up 11 years) and the Leiden 85-plus Study (median follow-up 5 years). PARTICIPANTS: Three thousand nine hundred ninety-four individuals, mean age 71, from the Rotterdam Study and 560 individuals, all aged 85, from the Leiden 85-plus Study. MEASUREMENTS: Global cognitive function was assessed in both cohorts using the Mini-Mental State Examination; attention, psychomotor speed, and memory function were assessed in the Leiden 85-plus Study only. Linear regression and linear mixed models were used for statistical analyses. RESULTS: In the Rotterdam Study, high serum calcium was associated with worse global cognitive function at baseline (P<.05) and a faster rate of decline in cognitive function during follow-up (P=.005) in individuals aged 75 and older but not in younger individuals. In the Leiden 85-plus Study, high serum calcium was associated with worse global cognitive function from age 85 through 90 (P<.001). This observation also held for the specific cognitive domains tested (all P<.01). These results did not change when individuals with serum calcium levels greater than normal (>2.55 mmol/L) were excluded from the analyses. CONCLUSION: In the general population, high serum calcium levels are associated with faster decline in cognitive function over the age of 75.
OBJECTIVES: To determine whether serum calcium is associated with cognitive function in elderly individuals in the general population. DESIGN: Prospective follow-up study of two independent, population-based cohorts. SETTING: The Rotterdam Study (median follow-up 11 years) and the Leiden 85-plus Study (median follow-up 5 years). PARTICIPANTS: Three thousand nine hundred ninety-four individuals, mean age 71, from the Rotterdam Study and 560 individuals, all aged 85, from the Leiden 85-plus Study. MEASUREMENTS: Global cognitive function was assessed in both cohorts using the Mini-Mental State Examination; attention, psychomotor speed, and memory function were assessed in the Leiden 85-plus Study only. Linear regression and linear mixed models were used for statistical analyses. RESULTS: In the Rotterdam Study, high serum calcium was associated with worse global cognitive function at baseline (P<.05) and a faster rate of decline in cognitive function during follow-up (P=.005) in individuals aged 75 and older but not in younger individuals. In the Leiden 85-plus Study, high serum calcium was associated with worse global cognitive function from age 85 through 90 (P<.001). This observation also held for the specific cognitive domains tested (all P<.01). These results did not change when individuals with serum calcium levels greater than normal (>2.55 mmol/L) were excluded from the analyses. CONCLUSION: In the general population, high serum calcium levels are associated with faster decline in cognitive function over the age of 75.
Authors: Virginie Lam; Matthew A Albrecht; Ryusuke Takechi; Prachya Prasopsang; Ya Ping Lee; Jonathan K Foster; John C L Mamo Journal: Eur J Nutr Date: 2015-07-01 Impact factor: 5.614
Authors: Alan A Cohen; Véronique Legault; Georg Fuellen; Tamàs Fülöp; Linda P Fried; Luigi Ferrucci Journal: Exp Gerontol Date: 2017-07-16 Impact factor: 4.032
Authors: Rebecca C Rossom; Mark A Espeland; Joann E Manson; Maurice W Dysken; Karen C Johnson; Dorothy S Lane; Erin S LeBlanc; Frank A Lederle; Kamal H Masaki; Karen L Margolis Journal: J Am Geriatr Soc Date: 2012-11-23 Impact factor: 5.562
Authors: Yanjun Zhao; Sivaprakash Sivaji; Michael C Chiang; Haadi Ali; Monica Zukowski; Sareen Ali; Bryan Kennedy; Alex Sklyar; Alice Cheng; Zihan Guo; Alexander K Reed; Ravindra Kodali; Jennifer Borowski; Georgia Frost; Patrick Beukema; Zachary P Wills Journal: Neuron Date: 2017-10-11 Impact factor: 17.173
Authors: Anna-Maija Tolppanen; Adrian Sayers; William D Fraser; Glyn Lewis; Stanley Zammit; John McGrath; Debbie A Lawlor Journal: PLoS One Date: 2012-07-25 Impact factor: 3.240